Alkem Laboratories has informed that a meeting of the Board of Directors of the Company is scheduled to be held on May 26, 2017, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017; and to consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2017.
The above information is a part of company’s filings submitted to BSE.